The presence of retraction clefts correlates with lymphovascular invasion and lymph node metastasis and predicts poor outcome: Analysis of 2497 breast cancer patients Journal Article


Authors: Li, W.; Jia, H.; Wang, S.; Guo, X.; Zhang, X.; Zhang, L.; Wen, H. Y.; Fu, L.
Article Title: The presence of retraction clefts correlates with lymphovascular invasion and lymph node metastasis and predicts poor outcome: Analysis of 2497 breast cancer patients
Abstract: Some invasive breast carcinomas are surrounded by a clear space that separate the tumor cells from the adjacent stroma, similar to invasive micropapillary carcinoma (IMPC), but lack the thin strands of connective tissue that separate the cells and characteristic “inside-out” growth pattern of IMPC on immunohistochemical stain for EMA. We consider the presence of the retraction clefts a common phenomenon that may present as a precursor stage of IMPC (PSIMPC). In this study, a total of 2497 cases of invasive breast carcinomas were prospectively collected. Among 2497 cases of breast cancer, 949 (38.0 %) cases were PSIMPC, 200 (8.0 %) cases were IMPC and 1348 (54.0 %) cases were IBC-NST. LVI was seen in128 of 200 (64 %) IMPC and 364 of 948 (38.0 %) PSIMPC, in contrast to 246 of 1341 (18 %) IBC-NST (P < 0.001). Lymph node metastasis was seen in 147 of 200 (73.4 %) IMPC and 551 of 949 (58 %) PSIMPC, in contrast to 563 of 1345 (42 %) IBC-NST (P < 0.001). The 5-year disease-free survival (DFS) and overall survival (OS) of PSIMPC were 76.8 % and 87.6 %, compared to 63.2 % and 85.9 % in IMPC, 86.2 % and 93.7 % in IBC-NST. PSIMPC demonstrated a more favorable DFS and OS compared to IMPC, but worse DFS and OS compared to IBC-NST. Cox and logistic regression analysis showed that PSIMPC was an independent predictor of DFS and OS. Our findings suggest that the presence of retraction clefts is a precursor state of IMPC, exhibiting IMPC-like features, such as higher incidence of lymphovascular invasion, lymph node metastasis and more aggressive clinical behavior. © 2022
Keywords: immunohistochemistry; adult; cancer survival; controlled study; human tissue; middle aged; major clinical study; overall survival; cancer patient; disease free survival; follow up; lymph node metastasis; breast cancer; epidermal growth factor receptor 2; lymph vessel; myoepithelium cell; estrogen receptor; progesterone receptor; logistic regression analysis; clinical outcome; lymphovascular invasion; invasive micropapillary carcinoma; survival prediction; cancer prognosis; lymph vessel metastasis; human; female; article; papillary carcinoma of the breast; retraction clefts
Journal Title: Annals of Diagnostic Pathology
Volume: 61
ISSN: 1092-9134
Publisher: Elsevier Inc.  
Date Published: 2022-12-01
Start Page: 152047
Language: English
DOI: 10.1016/j.anndiagpath.2022.152047
PROVIDER: scopus
PUBMED: 36156357
PMCID: PMC10083074
DOI/URL:
Notes: Article -- Export Date: 1 November 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Hannah Yong Wen
    301 Wen